Sherita Hill Golden

From WikiMD's Food, Medicine & Wellness Encyclopedia

Sherita Hill Golden is an American physician and medical researcher specializing in endocrinology, diabetes, and metabolism. She is currently the Hugh P. McCormick Family Professor of Endocrinology and Metabolism and Vice President and Chief Diversity Officer at the Johns Hopkins University School of Medicine.

Early Life and Education[edit | edit source]

Golden was born and raised in Baltimore, Maryland. She attended the University of Maryland, Baltimore County (UMBC), where she graduated summa cum laude with a degree in Chemical Engineering. She then attended the University of Virginia School of Medicine, where she earned her Doctor of Medicine degree.

Career[edit | edit source]

After completing her medical degree, Golden completed her residency in Internal Medicine at the Johns Hopkins Hospital. She then completed a fellowship in Endocrinology and Metabolism at the same institution.

Golden's research focuses on the mechanisms by which diabetes and stress contribute to the development of cardiovascular disease. She has published numerous articles in peer-reviewed medical journals and has received several awards for her research and teaching.

In 2020, Golden was appointed Vice President and Chief Diversity Officer at the Johns Hopkins University School of Medicine. In this role, she is responsible for promoting diversity and inclusion in the school's education, research, and clinical care programs.

Awards and Honors[edit | edit source]

Golden has received numerous awards and honors for her work, including the American Diabetes Association's Outstanding Scientific Achievement Award and the National Medical Association's Distinguished Service Award.

References[edit | edit source]


External Links[edit | edit source]

‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Admin, Prab R. Tumpati, MD